Skip to main content
. 2004 Mar;53(3):381–386. doi: 10.1136/gut.2003.027771

Table 2.

Proposed programme for surveillance and treatment of duodenal adenomatosis

Spigelman stage 0 Endoscopy* at intervals of 5 y
Spigelman stage I Endoscopy† at intervals of 5 y
Spigelman stage II Endoscopy† at intervals of 3 y
Spigelman stage III Endoscopy† at intervals of 1–2 y
Spigelman stage IV Endoscopic ultrasonography
Consider pancreas sparing or pylorus sparing duodenectomy

*Including multiple random biopsies from mucosal folds in patients without visible polyps.

†Including multiple biopsies from polyps.